Structure

 CRT Plenary Group is composed of: 

• ESC Board Members 
• Industry representatives from the cardiovascular field who paid a membership fee to join (2 representatives per company).

CRT Governance

The administration of the CRT is conducted by a group composed of Co-Chairs and Nucleus Members

CRT Co-Chairs: Job description 

The CRT is co-chaired by an ESC and an industry representative: 

• For the ESC, this is the President-Elect (2-year mandate)
• For industry, an election by the CRT Industry members for a 3-year mandate.

CRT Nucleus Members: Job description 

This group oversees the CRT activities and is composed of:

• CRT Co-Chairs
• ESC Members appointed by the ESC Co-Chair (2-year mandate)
• The previous Industry Chair as Advisor
• 7 elected industry representatives from each industry sector (2-year mandate aligned with the ESC mandate); elected by the industry members

The full composition of the CRT Nucleus will be known end of August after the appointments of the Academic Members and the 2nd round of elections for one position within the Industry members.

CRT Academic Members, mandate September 2024-August 2026

• Prof. Cecilia Linde : ESC President Elect and CRT Academic Chair, Sweden
• Dr. Christian John Fielder Camm, UK 
• Prof. Filippo Crea, Italy
• Dr. Victoria Delgado, Spain
• Prof. Stefan James, Sweden
• Prof. Christophe Leclercq, France
• Prof. Felix Mahfoud, Switzerland
• Prof. Susanna Price, UK 
• Prof. Piotr Szymanski, Poland

CRT Industry Members, mandate 2024-2026

• Prof. Alexandra Goncalves: CRT Industry Chair (elected until August 2025) Bristol-Myers Squibb (BMS)
• Dr. Isabelle Richard-Lordereau: Advisor (until August 2025) Amgen
• Dr. Ola Vedin: AztraZeneca 
• Dr. Andre Stuerzenbecher: Bayer AG 
• Dr. Bettina Kraus: Boehringer Ingelheim Pharmaceuticals Inc
• Mr. Andre Krueger: Novartis 
• Dr. Kristine Buchholtz: Novo Nordisk A/S
• Dr. Sanjay Gandhi: Philips
• Dr. André Ziegler: Roche Diagnostics International Ltd.